Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Modulation of Retinal Atrophy and Neurofilament Light Chain by Ofatumumab in Relapsing Multiple Sclerosis

NCT06167642 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT06167642
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06167642 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Modulation of Retinal Atrophy and Neurofilament Light Chain by Ofatumumab in Relapsing Multiple Sclerosis
Lead sponsor
Johns Hopkins University
Phase
Observational
Overall status
Enrolling by invitation
Start date
May 22, 2023
Completion date
March 31, 2027
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis, retinal degeneration, tomography, optical coherence, visual acuity